COMMUNIQUÉS West-GlobeNewswire

BioAge Labs to Present at Jefferies London Healthcare Conference
24/10/2024
RICHMOND, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the [...]
Tomi Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2024 Financial Results on October 30, 2024
24/10/2024
FREDERICK, Md., Oct. 24, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report [...]
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
23/10/2024
DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024
23/10/2024
LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to [...]
STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024
23/10/2024
DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 second quarter financial results at 9: [...]
Clover Health to Report Third Quarter 2024 Financial Results on November 6
23/10/2024
FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after market close on [...]
Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30
23/10/2024
SILVER SPRING, Md., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a leader in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, will [...]
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
23/10/2024
WARSAW, Ind., Oct. 23, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo
23/10/2024
Outset Medical features patient experience poster presentations at Kidney Week 2024 Consensus recommendations for use of catheters in home hemodialysis patients published in Kidney Medicine SAN JOSE, Calif., Oct. 23, [...]
WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call
23/10/2024
NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2024 before market open on Wednesday, November 6 [...]
Arcutis to Report Third Quarter 2024 Financial Results and Participate in an Upcoming Investor Conference
23/10/2024
Quarterly investor conference call and webcast is scheduled for Wednesday, November 6 at 4:30 p.m. ET Arcutis management will also participate in the Guggenheim Securities Healthcare Innovation Conference in November [...]
Cytokinetics to Announce Third Quarter Results on November 6, 2024
23/10/2024
SOUTH SAN FRANCISCO, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report third quarter results on November 6, 2024 at 4:00 PM Eastern Time. [...]
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
23/10/2024
CARSON CITY, Nev., Oct. 23, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]
Dans le cadre de la GHE 2024, le KFSHRC célèbre 40 ans de leadership dans le domaine des cellules souches
23/10/2024
Plus de 7 400 greffes de cellules souches ont été réalisées RIYAD, Arabie saoudite, 23 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSHRC) a fêté le 40e anniversaire de son [...]
Lung Health Foundation: New Evict Radon National Study Report Underscores ‘Urgent Need for Canada-Wide Advocacy’ to Reduce Dangerous Radon Levels in Canadian Homes
23/10/2024
Canada’s leading lung health organization supports and urges policy reforms through building codes, lung cancer screening and taxation policies TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Lung Health Foundation (LHF [...]
Ancilia Biosciences Selected to Receive $3 Million Award from ARPA-H’s Sprint for Women’s Health
23/10/2024
—Award from Highly Competitive Initiative Will Enable Ancilia to Advance Its Lead Program through IND Filing for Its First Clinical Trial— —Ancilia Also Awarded $274,000 NIH STTR Grant to Expand Its Platform to Diseases [...]
Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health
23/10/2024
DARE-HPV is a potential first-in-category treatment for human papillomavirus (HPV)-related cervical disease which could change the treatment paradigm for clinical HPV management. Essentially all cervical cancer cases [...]
Saudi Surgeon Honored for Performing the World’s First Fully Robotic Heart Transplant
23/10/2024
"Robotic Heart Surgery" at KFSHRC…A Leading and Accelerating Journey of Success RIYADH, Saudi Arabia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to set [...]
Orchard Therapeutics Announces Multiple Data Presentations and Publications
23/10/2024
Ten presentations at ESGCT 2024 detail the therapeutic potential and applicability of the company’s platform in rare neurometabolic diseases and beyond Nature manuscript highlights clinical results supporting long-term [...]

Pages